市場調査レポート

商品コード

1363168

上流バイオプロセスの市場規模、シェア、動向分析レポート：製品別、ワークフロー別、使用タイプ別、モード別、地域別、セグメント別予測、2023年～2030年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

出版日: 2023年09月22日 | 発行: Grand View Research

| ページ情報: 英文 145 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 931,651円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,088,231円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,401,391円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

上流バイオプロセス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の上流バイオプロセス市場規模は2023年から2030年にかけてCAGR 16.6%で拡大し、2030年には591億米ドルに達する見込みです。

バイオ医薬品の商業的成功と幅広い受容は、いくつかの自社製造だけでなく受託製造のバイオ医薬品企業にも有利な成長の道を提供しています。さらに、バイオシミラーや生物製剤の需要の高さ、費用対効果の高い改良技術の発売、シングルユースシステムの受け入れ拡大などの要因が重なり、市場の収益を押し上げています。

新興企業や新規参入企業は、バイオ製造プラントを新設する際に予算上の制約に直面することが多いです。そのため、これらの事業体は、製造プロセスを受託サービスに委託することでバイオ治療薬のポートフォリオを拡大し、上流バイオプロセスサービスの収益拡大に貢献しています。

連続的な上流バイオプロセスは、バイオプロセス産業に大きな利益をもたらしています。バイオリアクター培養の清澄化のために、音響波技術や連続遠心分離のような方法の導入が増加し、清澄化の負担が最小限になる傾向にあります。その結果、細胞培養の密度が高まり、効率的な上流工程が実現します。

タンパク質発現とクローン・スクリーニングに関する細胞株生産性の継続的な進歩により、予測期間中、細胞培養製品のCAGRが最も速くなると予想されます。細胞培養は、上流バイオプロセスにおいて最も困難で重要なステップと考えられているため、技術的な複雑さに関してより多くの注意が必要とされ、その結果、上流バイオプロセス市場で最大のシェアを占めています。

マルチユースシステムなどの要因は、投資が1回で済み、より大量のバイオプロセスに適用でき、pHと酸素を正確に維持するため、これらのシステムの使用率が高いことです。しかし、従来のステンレス製バイオリアクターからシングルユースバイオリアクターシステムへのパラダイムシフトが、シングルユース分野の有利な成長の要因となっています。

主要な市場企業は、市場での存在感を強化するために、新規製品の発展、互恵的パートナーシップ、協定、地理的拡大などの戦略的イニシアチブを採用しています。例えば、2019年2月、Danaher Corporationは、GE Life SciencesのBiopharma事業を買収する契約を締結しました。この買収により、ダナハーはGEバイオファーマの細胞培養培地、シングルユース技術、開発機器、消耗品を既存のポートフォリオに加え、市場でのプレゼンスを拡大しました。

上流バイオプロセス市場レポート・ハイライト

バイオリアクターの高い入手可能性と、主要プレーヤーによるシングルユース・バイオリアクターの継続的な発売が、バイオリアクターセグメントの顕著な収益シェアの要因となっています。
社内でバイオ生産を行うことができる老舗のバイオ医薬品製造企業が存在することが、このセグメントの最大収益シェアにつながっています。
上流バイオプロセスのアウトソーシングモードは、CMOによるシングルユースシステムの工場への統合を通じた投資の増加と製造能力の拡大により、予測期間中に最も速いCAGRを記録すると予測されています。
北米は、バイオテクノロジーにおける継続的な技術革新とバイオ医薬品に対する嗜好の高まりにより、世界の上流バイオプロセス市場を独占しています。さらに、バイオ医薬品メーカーが社内に多数存在し、米国のバイオ医薬品市場に多くの投資が行われていることも成長を後押ししています。
アジア太平洋地域は、上流のワークフローで工程内管理に使用できる迅速分析法に対する認識が高まっているため、予測期間中に最も速いCAGRを記録する見込みです。

上流バイオプロセス市場：重要なポイント
上流バイオプロセス市場：動向と市場シェア分析、2022年および2030年
バイオリアクター/発酵槽
- バイオリアクター/発酵槽市場推計・予測、2018年から2030年まで
細胞培養製品
- 細胞培養製品市場推計・予測、2018年から2030年まで
フィルター
- フィルター市場推計・予測、2018年から2030年まで
バイオリアクターアクセサリ
- バイオリアクター付属品市場推計・予測、2018年から2030年まで
袋・容器
- 袋と容器の市場推計・予測、2018年から2030年
その他
- その他の市場推計・予測、2018年から2030年まで

第5章上流バイオプロセス：ワークフローの推定・動向分析

上流バイオプロセス市場：重要なポイント
上流バイオプロセス市場：動向と市場シェア分析、2022年および2030年
メディアの準備
細胞培養
細胞の分離

第6章上流バイオプロセス：使用タイプの推定・動向分析

上流バイオプロセス市場：重要なポイント
上流バイオプロセス市場：動向と市場シェア分析、2022年および2030年
多用途
- 多用途市場推計・予測、2018年から2030年まで
シングルユース
- シングルユース市場推計・予測、2018年から2030年まで

第7章上流バイオプロセス：モード推定・動向分析

上流バイオプロセス市場：重要なポイント
上流バイオプロセス市場：動向と市場シェア分析、2022年および2030年
社内
外部委託

第8章上流バイオプロセス市場：地域推定・動向分析

地域別の見通し
地域別の上流バイオプロセス市場：重要なポイント
北米
- 市場推計・予測、2018～2030年
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- スウェーデン
- ノルウェー
- デンマーク
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

主要市場参入企業による最近の動向と影響分析
市場参入企業の分類
- GE HealthCare
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Corning, Inc.
- Sartorius AG
- Eppendorf AG
- Danaher
- Boehringer Ingelheim GmbH
- Applikon Biotechnology
- PBS Biotech, Inc.
- Lonza
- CellGenix GmbH
- Samsung BioLogics
- AGC Inc.
- VWR International, LLC

図表

List of Tables

Table 1 List of Abbreviations
Table 2 North America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 3 North America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 4 North America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 5 North America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 6 North America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 7 U.S. upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 8 U.S. upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 9 U.S. upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 10 U.S. upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 11 Canada upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 12 Canada upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 13 Canada upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 14 Canada upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 15 Europe upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 16 Europe upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 17 Europe upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 18 Europe upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 19 Europe upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 20 Germany upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 21 Germany upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 22 Germany upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 23 Germany upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 24 UK upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 25 UK upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 26 UK upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 27 UK upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 28 France upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 29 France upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 30 France upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 31 France upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 32 Italy upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 33 Italy upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 34 Italy upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 35 Italy upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 36 Spain upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 37 Spain upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 38 Spain upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 39 Spain upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 40 Sweden upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 41 Sweden upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 42 Sweden upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 43 Sweden upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 44 Norway upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 45 Norway upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 46 Norway upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 47 Norway upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 48 Denmark upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 49 Denmark upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 50 Denmark upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 51 Denmark upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 52 Asia Pacific upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 53 Asia Pacific upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 54 Asia Pacific upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 55 Asia Pacific upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 56 Asia Pacific upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 57 Japan upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 58 Japan upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 59 Japan upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 60 Japan upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 61 China upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 62 China upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 63 China upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 64 China upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 65 India upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 66 India upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 67 India upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 68 India upstream bioprocessing market, by mode (USD Billion) 2018 - 2030
Table 69 Australia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 70 Australia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 71 Australia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 72 Australia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 73 Thailand upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 74 Thailand upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 75 Thailand upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 76 Thailand upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 77 South Korea upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 78 South Korea upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 79 South Korea upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 80 South Korea upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 81 Latin America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 82 Latin America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 83 Latin America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 84 Latin America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 85 Latin America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 86 Brazil upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 87 Brazil upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 88 Brazil upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 89 Brazil upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 90 Mexico upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 91 Mexico upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 92 Mexico upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 93 Mexico upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 94 Argentina upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 95 Argentina upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 96 Argentina upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 97 Argentina upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 98 Middle East and Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 99 Middle East and Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 100 Middle East and Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 101 Middle East and Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 102 Middle East and Africa upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
Table 103 South Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 104 South Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 105 South Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 106 South Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 107 Saudi Arabia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 108 Saudi Arabia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 109 Saudi Arabia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 110 Saudi Arabia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 111 UAE upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 112 UAE upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 113 UAE upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 114 UAE upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
Table 115 Kuwait upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
Table 116 Kuwait upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
Table 117 Kuwait upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
Table 118 Kuwait upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Upstream bioprocessing: Market outlook
Fig. 8 Upstream bioprocessing: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Upstream bioprocessing market driver impact
Fig. 14 Upstream bioprocessing market restraint impact
Fig. 15 Upstream bioprocessing market strategic initiatives analysis
Fig. 16 Upstream bioprocessing market: Product movement analysis
Fig. 17 Upstream bioprocessing market: Product outlook and key takeaways
Fig. 18 Bioreactors/Fermenters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 Cell culture products market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Filters market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Bioreactors accessories market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Bags & containers market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Upstream bioprocessing market: Workflow movement analysis
Fig. 25 Upstream bioprocessing market: Workflow outlook and key takeaways
Fig. 26 Media preparation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Cell culture market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Cell separation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Upstream bioprocessing market: Use type movement analysis (USD Billion)
Fig. 30 Upstream bioprocessing market: Use type outlook and key takeaways
Fig. 31 Multi-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Single-use market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Upstream bioprocessing market: Mode movement analysis
Fig. 34 Upstream bioprocessing market: Mode outlook and key takeaways
Fig. 35 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Global upstream bioprocessing market: Regional movement analysis
Fig. 38 Global upstream bioprocessing market: Regional outlook and key takeaways
Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 India market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Product Code: GVR-3-68038-592-2

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.1 billion by 2030, expanding at a CAGR of 16.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Workflow
- 1.1.3. Use Type
- 1.1.4. Mode
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Workflow outlook
- 2.2.3. Use type outlook
- 2.2.4. Mode outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Upstream Bioprocessing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis

4.1. Upstream Bioprocessing Market: Key Takeaways
4.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Bioreactors/Fermenters
- 4.3.1. Bioreactors/Fermenters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Cell Culture Products
- 4.4.1. Cell culture products market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Filters
- 4.5.1. Filters market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Bioreactors Accessories
- 4.6.1. Bioreactors accessories market estimates and forecasts, 2018 to 2030 (USD Billion)
4.7. Bags & Containers
- 4.7.1. Bags & containers market estimates and forecasts, 2018 to 2030 (USD Billion)
4.8. Others
- 4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis

5.1. Upstream Bioprocessing Market: Key Takeaways
5.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Media Preparation
- 5.3.1. Media preparation market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Cell Culture
- 5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cell Separation
- 5.5.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis

6.1. Upstream Bioprocessing Market: Key Takeaways
6.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Multi-Use
- 6.3.1. Multi-use market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. Single-Use
- 6.4.1. Single-use market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis

7.1. Upstream Bioprocessing Market: Key Takeaways
7.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
7.3. In-House
- 7.3.1. In-house market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Outsourced
- 7.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Upstream Bioprocessing Market by Region: Key Takeaways
8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.3.2. U.S.
  - 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.3.3. Canada
  - 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.2. Germany
  - 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.3. France
  - 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.4. Italy
  - 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.5. Spain
  - 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.6. Sweden
  - 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.7. Norway
  - 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.8. Denmark
  - 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.2. China
  - 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.3. India
  - 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.4. Australia
  - 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.5. Thailand
  - 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.6. South Korea
  - 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.6.2. Mexico
  - 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.6.3. Argentina
  - 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.3. UAE
  - 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.4. Kuwait
  - 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
- 9.2.1. GE HealthCare
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Thermo Fisher Scientific Inc.
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Merck KGaA
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. Corning, Inc.
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Sartorius AG
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Eppendorf AG
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Danaher
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. Boehringer Ingelheim GmbH
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Applikon Biotechnology
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. PBS Biotech, Inc.
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives
- 9.2.11. Lonza
  - 9.2.11.1. Company overview
  - 9.2.11.2. Financial performance
  - 9.2.11.3. Product benchmarking
  - 9.2.11.4. Strategic initiatives
- 9.2.12. CellGenix GmbH
  - 9.2.12.1. Company overview
  - 9.2.12.2. Financial performance
  - 9.2.12.3. Product benchmarking
  - 9.2.12.4. Strategic initiatives
- 9.2.13. Samsung BioLogics
  - 9.2.13.1. Company overview
  - 9.2.13.2. Financial performance
  - 9.2.13.3. Product benchmarking
  - 9.2.13.4. Strategic initiatives
- 9.2.14. AGC Inc.
  - 9.2.14.1. Company overview
  - 9.2.14.2. Financial performance
  - 9.2.14.3. Product benchmarking
  - 9.2.14.4. Strategic initiatives
- 9.2.15. VWR International, LLC
  - 9.2.15.1. Company overview
  - 9.2.15.2. Financial performance
  - 9.2.15.3. Product benchmarking
  - 9.2.15.4. Strategic initiatives

上流バイオプロセスの市場規模、シェア、動向分析レポート：製品別、ワークフロー別、使用タイプ別、モード別、地域別、セグメント別予測、2023年～2030年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

上流バイオプロセス市場の成長と動向：

上流バイオプロセス市場レポート・ハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章上流バイオプロセス市場の変数、動向、範囲

第4章上流バイオプロセス：製品の推定・動向分析

第5章上流バイオプロセス：ワークフローの推定・動向分析

第6章上流バイオプロセス：使用タイプの推定・動向分析

第7章上流バイオプロセス：モード推定・動向分析

第8章上流バイオプロセス市場：地域推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Upstream Bioprocessing Market Growth & Trends:

Upstream Bioprocessing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope

Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis

Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis

Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis

Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

上流バイオプロセスの市場規模、シェア、動向分析レポート：製品別、ワークフロー別、使用タイプ別、モード別、地域別、セグメント別予測、2023年～2030年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

上流バイオプロセス市場の成長と動向：

上流バイオプロセス市場レポート・ハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 上流バイオプロセス市場の変数、動向、範囲

第4章 上流バイオプロセス：製品の推定・動向分析

第5章 上流バイオプロセス：ワークフローの推定・動向分析

第6章 上流バイオプロセス：使用タイプの推定・動向分析

第7章 上流バイオプロセス：モード推定・動向分析

第8章 上流バイオプロセス市場：地域推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Upstream Bioprocessing Market Growth & Trends:

Upstream Bioprocessing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope

Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis

Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis

Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis

Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章上流バイオプロセス市場の変数、動向、範囲

第4章上流バイオプロセス：製品の推定・動向分析

第5章上流バイオプロセス：ワークフローの推定・動向分析

第6章上流バイオプロセス：使用タイプの推定・動向分析

第7章上流バイオプロセス：モード推定・動向分析

第8章上流バイオプロセス市場：地域推定・動向分析

第9章競合情勢